Age-stratified reference ranges for adenoid hypertrophy in children: a single-center retrospective study

儿童腺样体肥大年龄分层参考范围:一项单中心回顾性研究

阅读:1

Abstract

INTRODUCTION: Adenoid hypertrophy (AH) is prevalent in 35%-70% of the global pediatric population, leading to airway obstruction and sleep disturbances. Current diagnostic criteria for the adenoid-to-nasopharyngeal (A/N) ratio lack age-specific adjustments, potentially resulting in diagnostic inaccuracies. METHODS: This retrospective study assessed pediatric outpatients aged 1-12 years who underwent lateral nasopharyngeal radiography. Measurements of adenoid depth (AD), nasopharyngeal depth (ND), and A/N ratios were recorded, and age-stratified percentiles (P5-P95) were calculated for four distinct age cohorts. The relationships between AD, ND, and A/N ratios and age were analyzed. Measurements were conducted by two independent radiologists, with any discrepancies adjudicated by a senior expert. RESULTS: In this investigation involving 2,629 outpatient children aged between 1 and 12 years, the median AD remained consistent at 14-15 mm, whereas ND increased from 21 to 27 mm, resulting in a decrease in the A/N ratio from 0.68 to 0.56. Pathological hypertrophy was identified in 42% of children aged 1-3 years, compared to 13.7% in those aged 10-12 years, with no significant sex-based differences observed. Age-specific reference ranges showed that both AD and ND increased with age, whereas the A/N ratio decreased. A positive correlation was found between AD and both ND and the A/N ratio, while ND exhibited a negative correlation with the A/N ratio. Significant discrepancies were noted between age-specific A/N ratio percentiles and the current fixed diagnostic criteria for children aged 1-12 years. The study established percentile-based reference values (P5-P95) for AD, ND, and the A/N ratio across four pediatric age groups. CONCLUSIONS: This study established percentile-based reference values (P5-P95) for AD, ND, and the A/N ratio across four pediatric age groups, thereby recommending age-specific diagnostic thresholds for AH in clinical settings.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。